The CommonHealth

As part of our series on China post-COVID-19, Chris Murray reflects on where things stand, almost two months after President Xi threw off Zero-Covid controls. A huge Covid-19 wave has likely led thus far to a million deaths. It is likely not over. Don’t expect greater Chinese government transparency on numbers. That remains a highly sensitive matter domestically and, no less important, an integral component of China’s foreign policy image and prestige. The Chinese government is driving to get through the outbreak as fast as possible, tough it out, and reopen the economy. China's elderly bear the biggest toll. 

In our continued series on China post-Zero Covid, Dr. Scott Kennedy recounts the revelations from his six weeks in Beijing and Shanghai in late 2022, and reflects on what has transpired – societally, politically, medically -- since President Xi suddenly threw off the Zero-Covid controls in early December.  What is the “toll” for not preparing for the colossal speak of Covid? What to make of a “crisis of confidence” that the government has to face, that is going to “hurt?” What can we expect in the spring in terms of “normalization?’

As 2023 opens, Yanzhong Huang, Council on Foreign Relations/Seton Hall University, kicks off our new podcast series focused on China. Over the past month, since Xi threw off Zero-Covid, China has experienced an extraordinary pace and scale of infection. “The worst is yet to come” as Lunar New Year migration rush – 200 million – spreads the virus into the countryside. Why should Americans care? Are travel restrictions counter-productive? How should we think about what lies on the other side of this extraordinary outbreak?

In this 153rd episode, Doctors Kristina Box and Judy Monroe walk us through the recently concluded Indiana Governor’s Commission on Public Health. Why Indiana? What are the Commission’s mandate, methods, findings and recommendations? How did Commissioners navigate the polarization and anger? Indiana’s $55 per capita investment in public health lags far behind the $91 national average: how is Indiana to catch up? What’s CDC’s special value to Indiana’s public health? How important is the Commission to the rest of the nation?  

In Episode 152, we share the audio of the one-hour conversation J. Stephen Morrison held at CSIS on October 19 with Dr. Raj Panjabi, Special Assistant to the President and Senior Director for Global Health Security and Biodefense at the National Security Council. The focus is the launch of the new U.S. National Biodefense Strategy and Implementation Plan and the issuance of the President’s National Security Memorandum-15. What do these steps promise, in strengthening the protection of Americans and advancing U.S. leadership globally? What is it going to take to ensure success, in terms of high-level sustained political will, sustained finances, and the partnership and mobilization of state and local authorities, industry, university researchers and others?

In this special CCU episode, #151, we bring you the audio of a conversation that J. Stephen Morrison held with Dr. Ashish Jha on September 27. How is the bivalent vaccine launch going? How does the White House navigate the wildly divergent realities of the pandemic? We are living a tale of two cities: the drive to normality, built on major achievements that have lowered the threat of severe illness and death, versus persistent danger and uncertainty, and the multiple accumulating barriers to action: the fiscal, political and technological impasses, and our frayed institutions. What are his reflections, six months into the job, on the role of the White House Coordinator? Will the White House exit an emergency context in early 2023? Give a listen!

In episode 150, Dr. Daskalakis, White House Deputy Coordinator of the monkey pox response, has been at his job for six weeks, attempting an urgent turnaround of a response that went very badly initially. He looks at “his medium term crystal ball” and sees several causes for cautious optimism: a deceleration of spread, changed behavior, greater vaccine availability, greater flexibility in use of HIV and STD resources, improved communications. But much progress still hangs on far more funding, better data flows, and bipartisan political support. Listen to hear more!

In this special episode, we bring you the audio of a broadcast interview that J. Stephen Morrison held on Monday, September 19 with Dr. Fauci, Chief Medical Advisor to President Biden and Director, the National Institute of Allergies and Infectious Diseases. Dr. Fauci addresses the multiple tough challenges that confront us, as we approach year 3 of the pandemic, as well as the historic achievements that give us hope. 

Dr. Krishna Udayakumar, founding director of the Duke Global Health Innovation Center, shares his trenchant insights into this confusing moment of transition in the global response to Covid-19. What should be the priorities and the principles to guide action? How to take account of the profound changes in the pandemic, while not losing focus on equity? Please give a listen!

On this 147th episode, we are offering the fireside chat, held on August 30 at CSIS, at which CDC Director Rochelle Walensky laid out her newly announced reform agenda, moderated by Julie Gerberding and Tom Inglesby. Julie is former director of the CDC and current director of the Foundation of the National Institutes of Health, and co-chair of the CSIS Commission on Strengthening America’s Health Security. Tom is Director of the Johns Hopkins University Center on Health Security and co-chair of the Commission Working Group on CDC.